Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nunzio Pomara

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
The American Journal of Psychiatry|January 6, 2009
Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophreniaNunzio Pomara
Critical Care Medicine|May 21, 2013
APOE-based psychopharmacogenetics and deliriumNunzio Pomara
The American Journal of Psychiatry|March 4, 2009
Suicidal behavior: The need for its documentation in multiaxial DSM-V diagnosesNunzio Pomara
Journal of Clinical Psychopharmacology|May 15, 2009
Apolipoprotein E epsilon4: an understudied potential pharmacodynamic risk factor of drug-induced cognitive toxicity in the elderlyNunzio Pomara
Psychopharmacology|March 21, 2009
Lithium treatment in Alzheimer's disease does not promote cognitive enhancement, but may exert long-term neuroprotective effectsNunzio Pomara
The New England Journal of Medicine|October 25, 2013
Semagacestat for treatment of Alzheimer's diseaseNunzio Pomara
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 17, 2016
Major Depression May Lead to Elevations in Potentially Neurotoxic Amyloid Beta Species Independently of Alzheimer DiseaseNunzio Pomara, Davide Bruno
Journal of the American Geriatrics Society|February 4, 2010
Apolipoprotein E epsilon4 and anticholinergic cognitive toxicityNunzio Pomara, John Sidtis
Evidence-Based Mental Health|April 20, 2011
Lower plasma β-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementiaNunzio Pomara, Davide Bruno
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Potential effects of the APOE epsilon2 allele and of family history of Alzheimer's disease on brain amyloid-β in normal elderlyNunzio Pomara, Davide Bruno
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
The American Journal of Psychiatry|January 6, 2009
Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophreniaNunzio Pomara
Critical Care Medicine|May 21, 2013
APOE-based psychopharmacogenetics and deliriumNunzio Pomara
The American Journal of Psychiatry|March 4, 2009
Suicidal behavior: The need for its documentation in multiaxial DSM-V diagnosesNunzio Pomara
Journal of Clinical Psychopharmacology|May 15, 2009
Apolipoprotein E epsilon4: an understudied potential pharmacodynamic risk factor of drug-induced cognitive toxicity in the elderlyNunzio Pomara
Psychopharmacology|March 21, 2009
Lithium treatment in Alzheimer's disease does not promote cognitive enhancement, but may exert long-term neuroprotective effectsNunzio Pomara
The New England Journal of Medicine|October 25, 2013
Semagacestat for treatment of Alzheimer's diseaseNunzio Pomara
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 17, 2016
Major Depression May Lead to Elevations in Potentially Neurotoxic Amyloid Beta Species Independently of Alzheimer DiseaseNunzio Pomara, Davide Bruno
Journal of the American Geriatrics Society|February 4, 2010
Apolipoprotein E epsilon4 and anticholinergic cognitive toxicityNunzio Pomara, John Sidtis
Evidence-Based Mental Health|April 20, 2011
Lower plasma β-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementiaNunzio Pomara, Davide Bruno
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Potential effects of the APOE epsilon2 allele and of family history of Alzheimer's disease on brain amyloid-β in normal elderlyNunzio Pomara, Davide Bruno
Pageof 11